| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |